| Name | Imatinib D4 |
|---|
| Description | Imatinib D4 (STI571 D4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H27D4N7O |
|---|---|
| Molecular Weight | 497.63 |
| Hazard Codes | Xi |
|---|